A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Global Paediatric Interventional Cardiology Market Analysis to 2029

Featuring Medtronic, NeMED, GE Healthcare and Boston Scientific Among Others

The “Paediatric Interventional Cardiology Market Analysis by Device Type and by Region – Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering.

The paediatric interventional cardiology market size is estimated to be USD 1,581.3 million in 2021 and is expected to witness a CAGR of 11.18% during the forecast period 2022-2029.

Companies Mentioned:

  • St. Jude Medical Inc. (U.S.)
  • Medtronic Inc. (U.S.)
  • W.L. Gore & Associates Inc. (U.S.)
  • Edwards Lifesciences Corp (U.S.)
  • NuMED Inc. (U.S.)
  • Cordis Corporation (U.S.)
  • GE Healthcare (U.K.)
  • Siemens Healthcare (Germany)
  • Boston Scientific (U.S.)
  • Abbott Vascular (U.S.)

The increased rates of congenital heart disease and FDA initiatives to streamline the regulatory process, technical advances, which have resulted in the introduction of new and improved products is expected to drive the market.

However, changing stringency of regulatory procedures and presence of complex regulatory procedures is expected to restrain the market growth.

By Device Type

Based on device type, the market is segregated into transcatheter heart valves and congenital heart defect closure devices. In 2021, the congenital heart defect closure devices segment accounted for the highest revenue share due to a rising understanding of the importance of paediatric interventional cardiology devices and rising instances of congenital impairments.

Regional Markets

In 2021, Asia Pacific region accounted for the highest revenue in the paediatric interventional cardiology market and is expected to maintain its dominance during the forecast period. The increase in government funding for developing paediatric care facilities, and investments by prominent players in the APAC region. are all contributing to the market expansion.

Segmentation: Paediatric Interventional Cardiology Market Report 2021-2029

By Device Type (Revenue, USD Million)

  • Transcatheter Heart Valves
  • Congenital Heart Defect Closure Devices

By Region (Revenue, USD Million)

North America

  • U.S
  • Canada


  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA

For more information about this report visit https://www.researchandmarkets.com/r/an873x

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Sachita Shah, Sr. Director, Global Health, Butterfly Network, "Butterfly is proud to continue improving maternal health equity through Phase Two of the largest-scale handheld ultrasound distribution and training ever conducted in Sub-Saharan Africa. South Africa is an emerging market that continues to have disproportionately high rates of maternal mortality and stillbirth. Patients need easier access to antenatal imaging, and clinicians need better capabilities for screening high-risk conditions that lead to disproportionately worse pregnancy outcomes in rural areas in the public sector. Together with CHAI and GUSI, we can tackle this by making ultrasound much more accessible, so high-risk conditions can be identified earlier in care, which is known to improve outcomes.”
The clinical Study will enroll up to 97 patients at up to 12 European investigational sites. Completion of the study is expected this year, and results will support CE mark and pre-market approval submissions reports Vivasure Medical.
Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.

By using this website you agree to accept Medical Device News Magazine Privacy Policy